13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000950123-23-008184
Total Value
$971.0M
Positions
32
Other Managers
11
Confidential Omitted
No
Holdings (32)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NUVALENT INC | NUVL | 3,577,267 | $150.9M | 15.54% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,473,913 | $124.5M | 12.83% |
| 3 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,081,307 | $80.8M | 8.32% |
| 4 | PHARVARIS N V | PHVS | 4,868,784 | $73.7M | 7.59% |
| 5 | DISC MEDICINE INC | IRON | 1,332,548 | $59.2M | 6.09% |
| 6 | CRINETICS PHARMACEUTICALS IN | CRNX | 2,305,558 | $41.5M | 4.28% |
| 7 | SAVARA INC | SVRA | 11,622,598 | $37.1M | 3.82% |
| 8 | ACLARIS THERAPEUTICS INC | ACRS | 3,400,000 | $35.3M | 3.63% |
| 9 | NATERA INC | NTRA | 700,197 | $34.1M | 3.51% |
| 10 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 2,415,000 | $31.2M | 3.21% |
| 11 | X4 PHARMACEUTICALS INC | XFOR | 15,960,588 | $31.0M | 3.19% |
| 12 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 3,000,000 | $28.6M | 2.94% |
| 13 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $28.5M | 2.94% |
| 14 | CYMABAY THERAPEUTICS INC | 23257D103 | 2,500,000 | $27.4M | 2.82% |
| 15 | CABALETTA BIO INC | CABA | 2,000,000 | $25.8M | 2.66% |
| 16 | ANNEXON INC | ANNX | 5,701,926 | $20.1M | 2.07% |
| 17 | EQRX INC | 26886C107 | 10,003,573 | $18.6M | 1.92% |
| 18 | NURIX THERAPEUTICS INC | NRIX | 1,822,883 | $18.2M | 1.88% |
| 19 | SOLID BIOSCIENCES INC | SLDB | 3,130,422 | $16.4M | 1.69% |
| 20 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 1,431,058 | $15.5M | 1.60% |
| 21 | 2SEVENTY BIO INC | 901384107 | 1,408,901 | $14.3M | 1.47% |
| 22 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $9.3M | 0.96% |
| 23 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $8.4M | 0.87% |
| 24 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 2,000,000 | $7.7M | 0.80% |
| 25 | XILIO THERAPEUTICS INC | XLO | 2,805,413 | $7.4M | 0.76% |
| 26 | SYROS PHARMACEUTICALS INC | 87184Q206 | 2,124,694 | $6.7M | 0.69% |
| 27 | TANGO THERAPEUTICS INC | TNGX | 1,921,790 | $6.4M | 0.66% |
| 28 | C4 THERAPEUTICS INC | CCCC | 1,642,210 | $4.5M | 0.47% |
| 29 | THIRD HARMONIC BIO INC | 88427A107 | 640,631 | $3.1M | 0.32% |
| 30 | CARA THERAPEUTICS INC | 140755109 | 934,898 | $2.6M | 0.27% |
| 31 | INVIVYD INC | IVVD | 1,937,207 | $2.0M | 0.21% |
| 32 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $209,000 | 0.02% |